SaponiQx, a leader in next-generation saponin-based adjuvant discovery and a subsidiary of Agenus Inc., today announced the publication of their latest preclinical data in the journal Vaccines. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback